Dmitriy Molchanov
Lawyers
Advises U.S. and international clients on a broad range of public and private mergers and acquisitions, private equity, and corporate governance matters.
Dmitriy advises U.S. and international clients on a wide range of public and private M&A transactions, including acquisitions and dispositions, carve-outs, going-private transactions, minority investments and joint ventures. He also advises clients on corporate governance, restructuring and general corporate matters.
Dmitriy’s clients span organizations in multiple industries, including technology, media and telecom, banking and finance, pharmaceuticals, consumer products and manufacturing.
Experience
Recent Work
- Nordson $800 million acquisition of Atrion
- Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
- Atairos investment in the parent company of the Aston Villa Football Club
- Summit Materials $3.2 billion combination with Argos USA
- Roper Technologies $1.25 billion acquisition of Syntellis Performance Solutions
- Natura $2.525 billion sale of Aesop to L’Oréal
- Arco Platform acquisition of isaac
- Emerson $3 billion sale of InSinkErator business to Whirlpool
- Industrial Media acquisition by Sony Pictures Television
- BDT Capital Partners acquires a majority interest in MJH Life Sciences
- Chosen Foods investment by Butterfly Equity
- Novo Nordisk acquisition of Neotope Neuroscience
- Loews adds GIC as a partner in Altium Packaging
- Crowdstrike $400 million acquisition of Humio
- KPS Capital Partners $2.1 billion acquisition of assets of Garrett Motion
- Applied Therapeutics, Inc. Initial Public Offering
Education
J.D., University of Pennsylvania Law School
- Senior Editor, University of Pennsylvania Law Review
M.B.A., University of Pennsylvania, Wharton School
B.A., Political Science, Carleton College
Qualifications and admissions
- State of New York